THTX

Theratechnologies Inc.

1.61 USD

Last updated Dec 6, 05:01 UTC

Yesterday HIGH

$1.71

Yesterday LOW

$1.61

52w HIGH

$5.76

52w LOW

$0.88

EPS

-0.03

PE

-53.67

Next Earnings

Feb 27, 2024

Overview News Government Trades

Theratechnologies Inc. stock is up 18.38% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 61.54% of the previous 12 December’s closed higher than November.

Theratechnologies Inc. focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

theratech.com

Benzinga Insights

Mon Jul 24, 2023

Stocks That Hit 52-Week Lows On Monday

On Monday, 70 companies achieved new lows for the year.
Benzinga Newsdesk

Thu Jul 20, 2023

Theratechnologies Plans 1-For-4 Reverse Stock Split

The Consolidation will be effective July 31, 2023, subject to applicable regulatory approvals, including the Toronto Stock Exchange (the "TSX") and the Nasdaq Stock Market ("NASDAQ").
Benzinga Newsdesk

Mon Jul 17, 2023

JonesTrading Maintains Buy on Theratechnologies, Lowers Price Target to $3

JonesTrading analyst Justin Walsh maintains Theratechnologies (NASDAQ:THTX) with a Buy and lowers the price target from $6 to $3.
richadhand@benzinga.com

Thu Jul 13, 2023

Cantor Fitzgerald Reiterates Overweight on Theratechnologies, Maintains $9 Price Target

Cantor Fitzgerald analyst Louis Chen reiterates Theratechnologies (NASDAQ:THTX) with a Overweight and maintains $9 price target.
Lisa Levin

Wed Jul 12, 2023

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
Lisa Levin

Wed Jul 12, 2023

S&P 500 Gains 1%; US Crude Oil Inventories Increase More Than Projected

U.S. stocks traded higher midway through trading, with the S&P 500 gaining 1% on Wednesday. The Dow traded up 0.84% to 34,550.13 while the NASDAQ rose 1.32% to 13,941.87. The S&P 500, also rose, gaining, 1.04% to 4,485.35.
Benzinga Newsdesk

Wed Jul 12, 2023

Theratechnologies Q2 Sales $17.55M Miss $22.00M Estimate; Net Loss Of $10.01M

Theratechnologies (NASDAQ:THTX) reported quarterly sales of $17.55 million which missed the analyst consensus estimate of $22.00 million by 20.23 percent. This is a 8.92 percent decrease over sales of $19.27 million the
Benzinga Insights

Wed Jul 12, 2023

Earnings Scheduled For July 12, 2023

Companies Reporting Before The Bell • Theratechnologies (NASDAQ:THTX) is projected to report quarterly loss at $0.06 per share on revenue of $22.00 million.
Benzinga Insights

Tue Jul 11, 2023

Theratechnologies Earnings Preview
richadhand@benzinga.com

Mon Jul 3, 2023

Canaccord Genuity Assumes Theratechnologies at Hold, Announces Price Target of $2

Canaccord Genuity analyst Edward Nash assumes Theratechnologies (NASDAQ:THTX) with a Hold rating and announces Price Target of $2.